- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC Commentary: U.S. Needs Evidence-Based Guidelines for Scheduling Follow-up Doctors' Visits
Are Doctors' Visits Set by Evidence or Habit? Extending Follow-ups Could Save Billions, Authors Say
FOR IMMEDIATE RELEASE JANUARY 23, 2014
AJMC Commentary: U.S. Needs Evidence-Based Guidelines for Scheduling Follow-up Doctors’ Visits
Are Visits Set By Need or By Habit? Extending Follow-ups Could Save Billions, Authors Say
PLAINSBORO, N.J. — The time has come for evidence-based guidelines for scheduling follow-up visits with doctors, a change that could trim billions from health care costs, according to the authors of a commentary published this month in The American Journal of Managed Care.
Despite nearly 1 billion annual outpatient follow-up visits in the United States, there’s not much data documenting the evidence base for follow-up intervals for costly chronic conditions. The current commentary seeks to establish follow-up intervals to reduce healthcare costs and improve access.
Considering that a major portion of outpatient office visits are follow-ups, the study considered the following questions: Are the visits and their time frames determined scientifically or by convenience and habit? Is there evidence to support a physicians practice patterns? And, if there is evidence to support practice patterns, do physicians adhere to the guidelines?
“Evidence-Based Guidelines to Determine Follow-up Intervals: A Call for Action,” by Emilia Javorsky, MPH; Amanda Robinson, MD; and Alexa Boer Kimball, MD, MP, followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines along with a PubMed database search for relevant studies for the top five chronic conditions with the highest outpatient visits in 2010 (mental disorders, back problems, arthritis, chronic obstructive pulmonary disease/asthma, hypertension), which cost an estimated $281 billion. For the full commentary, click here.
The authors modeled hypertension, which accounted for $47.4 billion in overall expenditure, and $13.03 billion in outpatient visits. Using the Medicare national allowable billing amount of $65.30 (Current Procedural Terminology code 99213 visit), they determined that an extension of the follow-up visit from six to seven months would result in a 15 percent decrease in visits per year, saving nearly $682 million. An extension to nine months would trim visits 34 percent, saving $1.5 billion, while an extension to annual visits would reduce visits by half and save $2.3 billion. The authors also predicted accurate blood pressure assessment and therapy adjustments.
Thus, the study concluded that evidence-based follow-up intervals must be established on healthcare outcomes to help reduce healthcare costs per person and improve access without compromising or restricting care.
CONTACT: Nicole Beagin or Mary Caffrey (609) 716-7777 x 131 or x 144
nbeagin@ajmc.com mcaffrey@ajmc.com
www.ajmc.com Follow us on Twitter @AJMC_Journal
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
